These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7620901)

  • 41. Cholinergic and serotonergic activities are required in triggering conditioned NK cell response.
    Hsueh CM; Chen SF; Lin RJ; Chao HJ
    J Neuroimmunol; 2002 Feb; 123(1-2):102-11. PubMed ID: 11880155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mu-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides.
    Gunion MW; Rosenthal MJ; Morley JE; Miller S; Zib B; Butler B; Moore RD
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R70-81. PubMed ID: 1677542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lidocaine interrupts the conditioned natural killer cell response by interfering with the conditioned stimulus.
    Rogers CF; Ghanta VK; Demissie S; Hiramoto N; Hiramoto RN
    Neuroimmunomodulation; 1994; 1(5):278-83. PubMed ID: 8528893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indomethacin and sodium carbonate effects on conditioned fever and NK cell activity.
    Rogers C; Ghanta V; Hsueh CM; Hiramoto N; Hiramoto R
    Pharmacol Biochem Behav; 1992 Oct; 43(2):417-22. PubMed ID: 1438480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of endogenous and exogenous opioids on splenic natural killer cell activity.
    Kraut RP; Greenberg AH
    Nat Immun Cell Growth Regul; 1986; 5(1):28-40. PubMed ID: 3010087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma beta-endorphin and natural killer cell activity in major depression: a preliminary study.
    Darko DF; Irwin MR; Risch SC; Gillin JC
    Psychiatry Res; 1992 Aug; 43(2):111-9. PubMed ID: 1410068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of specific pathways of communication between the CNS and NK cell system.
    Hiramoto R; Ghanta V; Solvason B; Lorden J; Hsueh CM; Rogers C; Demissie S; Hiramoto N
    Life Sci; 1993; 53(7):527-40. PubMed ID: 8350666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages.
    Ichinose M; Asai M; Sawada M
    J Neuroimmunol; 1995 Jul; 60(1-2):37-43. PubMed ID: 7642746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Release of beta-endorphin immunoreactivity into ventriculo-cisternal perfusate by lumbar intrathecal capsaicin in the rat.
    Bach FW; Yaksh TL
    Brain Res; 1995 Dec; 701(1-2):192-200. PubMed ID: 8925284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple, single, trial-learning paradigm for conditioned increase in natural killer cell activity.
    Solvason HB; Ghanta VK; Soong SJ; Rogers CF; Hsueh CM; Hiramoto NS; Hiramoto RN
    Proc Soc Exp Biol Med; 1992 Feb; 199(2):199-203. PubMed ID: 1741412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of reserpine on retention of the conditioned NK cell response.
    Hiramoto R; Solvason B; Ghanta V; Lorden J; Hiramoto N
    Pharmacol Biochem Behav; 1990 May; 36(1):51-6. PubMed ID: 2349268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opioid activity of beta-endorphin-like proteins from Tetrahymena.
    Rodriguez E; Lazaro MI; Renaud FL; Marino M
    J Eukaryot Microbiol; 2004; 51(1):60-5. PubMed ID: 15068266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of antibodies to dynorphin A and beta-endorphin on lateral hypothalamic self-stimulation in ad libitum fed and food-deprived rats.
    Carr KD
    Brain Res; 1990 Nov; 534(1-2):8-14. PubMed ID: 1981487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of dexamethasone on conditioned enhancement of natural killer cell activity.
    Hsueh CM; Rogers C; Hiramoto RN; Ghanta VK
    Neuroimmunomodulation; 1994; 1(6):370-6. PubMed ID: 7671125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquisition of enhanced natural killer cell activity under anesthesia.
    Hsueh CM; Lorden JF; Hiramoto RN; Ghanta VK
    Life Sci; 1992; 50(26):2067-74. PubMed ID: 1608290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
    Saurer TB; Ijames SG; Carrigan KA; Lysle DT
    Brain Behav Immun; 2008 Jan; 22(1):89-97. PubMed ID: 17689049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of anti-opioid peptide sera on oxytocin-induced enhancement of electroacupuncture analgesia].
    Song CY; Liu WY; Gu XY; Lin BC
    Sheng Li Xue Bao; 1993 Jun; 45(3):231-6. PubMed ID: 7901915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antagonism of nitrous oxide antinociception in mice by intrathecally administered antisera to endogenous opioid peptides.
    Cahill FJ; Ellenberger EA; Mueller JL; Tseng LF; Quock RM
    J Biomed Sci; 2000; 7(4):299-303. PubMed ID: 10895052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.